Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?

@article{Matthys2014ReviewOG,
  title={Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?},
  author={Frederik Matthys and T. D. de Backer and G. De Backer and R. V. Stichele},
  journal={European Journal of Preventive Cardiology},
  year={2014},
  volume={21},
  pages={354 - 365}
}
Aims There are numerous national and international guidelines on the use of aspirin for the primary prevention of cardiovascular disease. Given the uncertainties about aspirin in primary prevention, our aim was to compare the recommendations and the reported evidence in guidelines for the treatment with aspirin of subjects free of cardiovascular disease with or without diabetes. Methods and Results Guidelines were retrieved through Medline and other electronic databases and through a web-based… Expand
View on SAGE
ncbi.nlm.nih.gov
18 Citations
Highly Influential Citations
2
Background Citations
2
Methods Citations
1
Results Citations
1

18 Citations

Citation Type

Citation Type

Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force
Aspirin Use and Mortality in Two Contemporary US Cohorts
Cardiovascular Risk Assessment in Low-resource Settings: a Consensus Document of the European Society of Hypertensionworking Group on Hypertension and Cardiovascular Risk in Low Resource Settings , for the Esh Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings
    Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings
    Pooled RCTs: Low-dose ASA reduced CV events in persons <70 kg; higher-dose ASA was effective at higher body weights
    Clinicians’ opinions on recommending aspirin to prevent colorectal cancer to Australians aged 50–70 years: a qualitative study
    Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study
    A Geripill for Successful Aging
    • T. Strandberg
    • Medicine
    • Journal of the American Geriatrics Society
    • 2013
    Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study
    Disparities in Hypertension in the Ethnic Minority Groups: Beneficial Aspects of Minority Ethnic Group Cultures
    ...
    1
    2
    ...

    References

    SHOWING 1-10 OF 94 REFERENCES
    Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale
    Aspirin for primary prevention: yes or no?
    Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis
    Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.
    An update on aspirin in the primary prevention of cardiovascular disease.
    Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice
    Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies.
    Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force
    ...
    1
    2
    3
    4
    5
    ...